We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+14.33%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$40.3B
AUM Growth
+$2.76B
(+7.3%)
Cap. Flow
-$1.55B
Cap. Flow
% of AUM
-3.85%
Top 10 Holdings %
Top 10 Hldgs %
13.58%
Holding
2,266
New
182
Increased
649
Reduced
1,111
Closed
232
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GoDaddy
GDDY
|
+$83M |
| 2 |
Morgan Stanley
MS
|
+$67.7M |
| 3 |
Structure Therapeutics
GPCR
|
+$66.3M |
| 4 |
AbbVie
ABBV
|
+$63.8M |
| 5 |
Kenvue
KVUE
|
+$60.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$207M |
| 2 |
Williams Companies
WMB
|
+$150M |
| 3 |
Verizon
VZ
|
+$128M |
| 4 |
SPLK
Splunk Inc
SPLK
|
+$123M |
| 5 |
Cisco
CSCO
|
+$93.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.22% |
| 2 | Technology | 16.21% |
| 3 | Financials | 12.58% |
| 4 | Industrials | 9.78% |
| 5 | Consumer Discretionary | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Harmony Biosciences
HRMY
$2.08B
| $17M | 0.04% |
525,337
+501,809
| +2,133% | +$14M |
|
427
FTI Consulting
FCN
$5.14B
| $17M | 0.04% |
85,123
+1,110
| +1% | +$230K |
|
428
3M
MMM
$91.8B
| $16.9M | 0.04% |
185,170
+22,849
| +14% | +$1.83M |
|
429
Icon
ICLR
$13.7B
| $16.9M | 0.04% |
59,583
-901
| -1% | -$233K |
|
430
Revvity
RVTY
$12.6B
| $16.8M | 0.04% |
153,494
+866
| +0.6% | +$83.5K |
|
431
Xponential Fitness
XPOF
$286M
| $16.8M | 0.04% |
1,300,000
-235,000
| -15% | -$3.18M |
|
|
WCC
432
WESCO International
WCC
$15.1B
| $16.7M | 0.04% |
95,822
+35,316
| +58% | +$5.29M |
|
433
Knife River
KNF
$4.33B
| $16.6M | 0.04% |
251,567
+245,475
| +4,029% | +$14M |
|
434
PROG Holdings
PRG
$1.71B
| $16.6M | 0.04% |
538,472
-17,091
| -3% | -$502K |
|
435
Lowe's Companies
LOW
$121B
| $16.6M | 0.04% |
74,577
-8,177
| -10% | -$1.66M |
|
436
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
| $16.4M | 0.04% |
+183,840
| New | +$15.5M |
|
437
Coca-Cola Consolidated
COKE
$12.8B
| $16.3M | 0.04% |
175,880
-9,310
| -5% | -$674K |
|
|
BDN
438
Brandywine Realty Trust
BDN
$509M
| $16.3M | 0.04% |
3,017,941
+48,959
| +2% | +$215K |
|
439
NVR
NVR
$17.1B
| $16.1M | 0.04% |
2,302
-20
| -0.9% | -$123K |
|
440
Exelon
EXC
$48.1B
| $16.1M | 0.04% |
447,414
-156,452
| -26% | -$6.03M |
|
441
Lamb Weston
LW
$7.42B
| $16M | 0.04% |
148,119
-93,280
| -39% | -$8.98M |
|
442
Klaviyo
KVYO
$5.8B
| $16M | 0.04% |
+575,276
| New | +$17M |
|
443
Xenon Pharmaceuticals
XENE
$6.1B
| $16M | 0.04% |
+346,596
| New | +$12.2M |
|
444
Terex
TEX
$7.37B
| $16M | 0.04% |
277,672
-9,834
| -3% | -$508K |
|
445
Procore
PCOR
$7.57B
| $15.9M | 0.04% |
229,641
-85,257
| -27% | -$5.26M |
|
446
Novanta
NOVT
$4.91B
| $15.9M | 0.04% |
94,376
-230,151
| -71% | -$33.5M |
|
447
Dynatrace
DT
$12.7B
| $15.9M | 0.04% |
289,828
-5,781
| -2% | -$292K |
|
448
Progressive
PGR
$128B
| $15.8M | 0.04% |
99,400
+64,612
| +186% | +$10.1M |
|
449
LiveRamp
RAMP
$2.29B
| $15.7M | 0.04% |
415,447
-344,789
| -45% | -$11.1M |
|
450
e.l.f. Beauty
ELF
$4.77B
| $15.7M | 0.04% |
108,687
-81,475
| -43% | -$9.4M |
|
Similar funds
Federated Hermes's Q4 2023 Portfolio in Review
As of Q4 2023, Federated Hermes held 2,266 positions worth $40.3B, up 7.3% from $37.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Federated Hermes withdrew a net $1.55B in Q4 2023, closing 232 positions and reducing 1,111 holdings. Its most notable exit was Splunk Inc, an estimated $123M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Financials.
Against the trend, Federated Hermes opened a new position in Zscaler worth $39.2M.
- Federated Hermes's largest Q4 2023 buy was Zscaler: 177,136 shares worth $39.2M.
- Federated Hermes added most to GoDaddy in Q4 2023, an estimated $83M increase.
- Federated Hermes's biggest Q4 2023 reduction was Amgen, cutting an estimated $207M.
- Federated Hermes fully exited Splunk Inc in Q4 2023, selling an estimated $123M.
- Federated Hermes's ten largest holdings make up 14% of its $40.3B portfolio in Q4 2023.
- Federated Hermes opened 182 new positions and closed 232 in Q4 2023.
- Federated Hermes's portfolio value rose 7.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q4 2023, filed 31 Jan 2024.